Status:
UNKNOWN
the Quality of Life Assessment of Lung Cancer Patients in China
Lead Sponsor:
Sun Yat-sen University
Conditions:
Lung Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
The goal of this study is assess the quality of life of advanced non-small cell lung cancer (NSCLC) patients who are undergoing first-line chemotherapy, analyze the current status and tendency of qual...
Detailed Description
1. Lung cancer is the most deadly cancer in the world, 85% lung cancer are non-small cell lung cancer (NSCLC). The quality of life of NSCLC patients become more and more important, because of most NSC...
Eligibility Criteria
Inclusion
- age: \>18 and \<75 years old
- pathological or cytological diagnosis confirmed advanced non-small cell lung cancer
- Eastern Cooperative Oncology Group Performance Status: 0-2
- have never receive any kind of anti-cancer chemotherapy
- agree to regularly assessment of quality of life
- sign the informed consent form
Exclusion
- Currently attending any antitumor drug clinical trials
- Pregnancy or breast-feeding women
- Currently receiving anti-tumor chemotherapy, or received any antitumor chemotherapy previously.
- not suitable to participate in this test
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2017
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT01914120
Start Date
November 1 2012
End Date
June 1 2017
Last Update
August 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China, 510030